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INTRODUCTION 
Eczema (also called 'dermatitis') is a common 
skin condition that can affect up to 10% of the 
population at some time of their lives. In certain 
cases the condition may be severe and incapacitat-
ing. The word 'eczema' is derived from an ancient 
Greek word meaning 'to boil over'. Although many 
patients who have eczema have dry, sometimes 
flaky skin, when the condition flares up vesicles 
and blisters that may weep and crusts appear. 
Although eczema may become infected, in itself it 
is not contagious. There are several different types 
and causes of eczema. The commonest type is 
called 'atopic eczema'. The word 'atopy' was intro-
duced by Coca 1 in 1923 as a convenient collective 
term for a group of diseases, chief among which are 
asthma, hay fever and eczema, which occur spon-
taneously in individuals who have a family history 
of susceptibility. In fact some 75% of patients with 
atopic eczema have a personal or family history of 
asthma or hay fever or both. Atopic eczema usually 
appears before the age of one year however it may 
develop later in childhood or even in adulthood . 
Causation2 
The underlying cause of atopic eczema is still 
unknown. There is no convincing evidence that 
food intolerance, including food allergy, is more 
than occasionally present or relevant. Raised se-
rum IgE concentrations appear to be a secondary 
phenomenon due to imbalance of immunoregulatory 
T-cells, defined by a preponderance of the CD4+ 
TH2 helper T -cell subset. The skin of patients with 
eczema appears to be intrinsically hyper-reactive, 
resulting in a lower than normal itch threshold to 
chemical, mechanical and other stimuli, analogous 
to individuals with asthma who develop bronchos-
pasm at much lower concentrations of inhaled 
histamine or metacholine than do normal individu-
als . 
Clinical features 
The diagnosis of eczema is usually clinical and 
straightforward. Diagnostic guidelines that are use-
ful in epidemiological studies are available (Table 
1).3 In very young children, the first symptom is 
often slightly red or dry skin on the forehead and 
cheeks (Fig la). The dry skin then becomes itchy, 
red and inflamed. Sometimes the skin in only a few 
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places is affected but in more severe cases the 
eczema may cover the whole body. Most com-
monly affected are the neck, cheeks, hands, wrists, 
ankles, feet and the skin in the creases of the 
elbows and the back of the knees (Figs1b, c). 
The main symptom of eczema is itching. This 
can be severe and distressing both for the patient 
and, particularly in the case of children, for their 
parents who may feel unable to help. The itch can 
be so irritating that children are naturally driven to 
scratch - even babies, too young to scratch, will rub 
their faces against anything close enough in a 
desperate attempt to relieve the itching. Unfortu-
nately this breaks the skin and leaves it open to 
infection. The affected skin may also blister, weep 
and crust. If the eczema is repeatedly scratched or 
rubbed the skin may become thickened and rough 
(lichenification) . 
General Management 
Although the tendency to eczema cannot be 
cured, correct management can make a big differ-
ence to keep the patient comfortable and prevent 
complications. Aggravating factors should be iden -
tified and avoided where possible. Various emol -
lients are available to reduce the dryness of the 
skin. Other useful treatments include steroid creams 
and ointments, antibiotics to treat infection and 
antihistamines to reduce itching. 
Factors that may aggravate eczema 
There are many external factors that may influ-
ence eczema on a day-to-day basis. Aggravating 
factors should be identified and avoided where 
possible. Contact eczema may be caused by both 
irritant and allergic factors. Irritant factors include 
soaps and detergents (especially 'bubble-baths'), 
solvents, alkalis, abrasive dusts, heat, woollen cloth-
ing and even chlorine in swimming pool water. 
Occupations where there is a greater risk of devel-
oping irritant contact eczema include any form of 
wet or persistently dry work such as food handling, 
hairdressing, nursing, housework and building work. 
Allergic contact eczema results from a delayed 
hypersensitivity (type IV) reaction. This requires 
prior exposure to the allergen, leading to formation 
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of 'memory' T -cells that recognize the antigen on 
re-exposure and then become activated to produce 
cytokines that recruit more inflammatory cells. The 
inflammatory reaction thus arises after a latent 
period, often taking up to 48 hours and occasion -
ally longer to appear. Contact eczema may be 
investigated using patch testing. Suitably prepared 
dilutions of potential allergens in a bland vehicle 
are applied to the patient's back in small alu -
minium chambers, kept in place with hypoallergenic 
adhesive tape. These are normally removed after 
48 hours and the skin examined for eczematous 
reactions at the test sites. A further reading is made 
at 96 hours to help differentiate irritant from aller-
gic reactions. Some common skin allergens and 
their sources are listed in Table 2. It is worth noting 
that patch testing is of no value in the investigation 
of urticaria. 
Eczema may also be aggravated by stress, furry 
animals such as cats and dogs, and pollen and 
tends to be worse in spring. Sunshine in moderation 
usually helps. Children who have eczema may 
attend a normal school but may need to take 
certain precautions to avoid flaring up their condi -
tion. The role of diet in atopic eczema has long been 
controversial. Although some patients, especially 
young children, undoubtedly appear to react to 
certain foods, food allergy is not as relevant as 
generally thought. Furthermore no reliable screen-
ing tests exist so far. Response to diet is not more 
common in patients with high IgE, nor in those with 
positive prick or RAST tests to suspect foods. The 
advice of a qualified dietician should be sought 
before embarking on exclusion diets in young chil-
dren. 
Emollients 
Eczematous skin is usually dry and has a re-
duced barrier function. Various excellent emol-
lients are available which if used regularly help 
reduce the dryness, restore the barrier function and 
protect the skin from further damage. In general, 
moisturizing ointments (which are greasy) are more 
effective than creams or lotions; however the latter 
rub into the skin more easily and are less messy so 
most patients find them more convenient. A rea -
sonable compromise is to use a cream or lotion 
during the day and an ointment in the evening. 
Emollients can in fact be used as often as neces-
sary. It is particularly important to apply emollients 
after bathing and hand washing because washing 
the skin tends to cause further dryness. Bath oils 
are a lso helpful leaving a light film of oil on the skin 
surface that supplements natural oils and reduces 
moisture loss. Some bath oils also have a cleansing 
effect on the skin reducing the need to use soap. 
Patients should be warned that bath oils might 
make the bath slippery. Ordinary soap and 'bubble 
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- baths ' dry the skin and should be avoided. After 
bathing the skin should be dried by gently patting 
with a soft towel rather than towelling vigorously. 
Topical steroids 
Topical steroids are very useful and many times 
essential in the management of atopic eczema. 
Nevertheless they can cause several problems and 
should be treated with respect. Patients should use 
the weakest strength necessary to control their 
eczema and apply the steroid only when required. 
Make sure patients do not use a topical steroid 
where a simple emollient will do . Potential local 
complications of topical steroids include skin atro-
phy (striae (Fig 2), purpura, telangiecteses and 
poor wound healing) , hypertrichosis , folliculitis, 
pigmentary changes , spread of fungal infections 
and worsening of acne and rosacea . Inhibition of 
the pituitary-adrenal axis and other side-effects 
from systemic absorption of topically applied ster-
oids are documented but uncommon. Potent ster-
oids applied around the eyes may cause cataracts 
and glaucoma and should be strictly avoided . In 
general, the adverse effects of topical steroids are 
related to their potencies although some new ster-
oids are claimed to produce less skin atrophy and 
other side-effects than older products of similar 
strengths. Allergic contact dermatitis to the steroid 
molecule may also occur and is easily overlooked. 4 
Promising non-steroid immunomodulatory topical 
drugs are being developed at present and these 
may well revolutionise the treatment of eczema and 
other dermatoses in future. 
Infections, superantigens and antibiotics. 5 
The skin in atopic eczema is frequently colo-
nized by bacteria particularly staphylococcus 
aureus . These bacteria can produce exotoxins with 
superantigenic properties. This results in stimula-
tion of the immune system with T -cells being acti-
vated to release cytokines. The cytokine interleukin -
4 (IL-4) is found in high levels in patients with 
atopic eczema. IL-4 stimulates B-cells to produce 
IgE, which binds to mast cells. These release pro -
inflammatory mediators, which lead to inflamma-
tion and then eczema . Combinations of topical 
antibiotics and steroids are useful in the manage-
ment of mildly infected eczema especially in chil-
dren; severe infections should be treated with sys-
temic antibiotics. Eczema sufferers are also prone 
to infection with the poxvirus (causing molluscum 
contagiosum) and the herpes simplex virus (caus -
ing 'eczema herpeticum'). Eczema herpeticum may 
be a severe illness and should be treated with 
systemic antivirals. 
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Previous Page: 
Figure 1 a, b & c: Eczema on the face and in the 
creases of the elbows and knees (Leo pharma -
ceuticals, Denmark) 
Left & Bottom: 
Figure 2a & b: Topical steroid-induced striae, 
folliculitis and acne. 
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Antihistamines 
Both sedating and non sedating antihistamines 
are useful in the management of atopic eczema, 
especially if there is an urticarial element. 
Other treatments 
Phototherapy, systemic steroids and drugs such 
as cyclosporin and azathioprine have a place in the 
management of severe eczema. 
Prognosis 
Atopic eczema tends to improve with age how-
ever it is impossible to prophesy the prognosis in a 
particular child: 50% of children are clear by the 
age of 6 years, and 90% are clear by the age of 15 
years. 6 In many cases, however, individuals who 
had eczema in childhood continue to have skin that 
is more dry and 'sensitive' than normal. In some the 
eczema will reappear later on in life and this em-
phasizes the importance of long-term follow up 
when one talks of prognosis in atopic eczema. 
Older children who still have eczema should be 
given career advice early and encouraged to avoid 
occupations such as food handling and catering, 
hairdressing, nursing, building work and others 
likely to make their condition worse. 
Malta Eczema Society 
Unfortunately keeping eczema under control 
can sometimes be difficult (and expensive). 
Eczema is often chronic and may have a pro-
found effect on the quality of life of affected 
individuals and their families. Although eczema 
is of course not contagious, those affected may 
feel isolated and even embarrassed by their 
condition. To help those affected cope with 
their condition, a voluntary support group for 
persons with eczema and their families has 
recently been set up in Malta and named the 
Malta Eczema Society. The need for such a 
group in Malta, as found in other countries, has 
been felt for some time. An inaugural meeting of 
the new society was held on Monday 30th April 
2001 at the Catholic Institute, floriana and was 
well attended. It is hoped that the society will be 
able to help by providing support, information 
and practical adVice. Another aim is to increase 
awareness throughout society about eczema 
and the problems it may cause. There is a lot 
that can be done to improve the quality of life for 
persons with eczema and hopefully the group 
will be successful. The members of the organ-
izing committee are all volunteers. If you have 
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any patients who you feel would benefit from 
joining the Malta Eczema Society or who would 
like to be informed about future activities please 
encourage them to contact one of the following 
members of the organizing committee for fur -
ther information: Mrs Anna Baldacchino (tel 
386850), Mrs Marlene Bongalais (tel 435649) 
or Mr Herbert Debono (tel 335140). 
Dr M. J. Boffa is Consultant Dermatologist at 
Sir Paul Boffa Hospital and founder of the Malta 
Eczema Society. 
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Table 1 Diagnostic guidelines for atopic 
eczema 
Must have: 
An itchy skin condition (or parental report of 
scratching or rubbing in a child) 
Plus three or more of the following: 
* History of involvement of the skin creases, 
such as folds of elbows, behind the knees, 
fronts of ankles or around the neck (including 
cheeks in children under ten) 
* A personal history of asthma or hay fever (or 
history of atopic disease in a first degree rela-
tive in children under four) 
* A history of a generalised dry skin in the last 
year 
* Visible flexural eczema (or eczema involving 
the cheeks/forehead and outer limbs inchil-
dren under four) 
* Onset under the age of two (not used if child is 
under four) 
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Table 2 Common contact allergens and their 
sources 
Allergen Source 
Nickel Costume 
jewellery, watch straps 
Chromate Cement, leather 
Rubber chemicals Gloves, shoes, tyres 
Colophony Sticking plaster 
Wool alcohoIs Lanolin, moisturizing 
creams, cosmetics 
Balsam of Peru Perfumes 
Paraphenylenediamine Hair dyes, clothing dyes 
Parabens Preservative in creams, 
cosmetics 
Epoxy resins Adhesives 
Neomycin Topical antibiotic 
Benzocaine Topical local 
anaesthetic 
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